Tricuspid Regurgitation: Disease State and Advances in Percutaneous Therapy

Tricuspid regurgitation (TR) is a relatively common finding. There has been growing recognition of the morbidity and adverse prognosis of severe TR, which affects 1.6 million people in the US. However, symptomatic TR remains undertreated despite emerging therapeutic modalities. In this review, the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Qiuyu Martin, Berry, Natalia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2023
Materias:
Interventions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583156/
https://www.ncbi.nlm.nih.gov/pubmed/37860699
http://dx.doi.org/10.15420/ecr.2023.09

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583156/
https://www.ncbi.nlm.nih.gov/pubmed/37860699
http://dx.doi.org/10.15420/ecr.2023.09

Ejemplares similares